Watson for oncology decision system for treatment consistency study in breast cancer
Yaobang Liu(Ningxia Medical University), Xinlan Liu(Yunnan Agricultural University), Xingfa Huo(Qingdao University), Dengfeng Ren(Qinghai University Affiliated Hospital), Jiuda Zhao(Qinghai University), Qi Li(China National Center for Food Safety Risk Assessment), Zhen Liu(Qingdao University), Fuxing Zhao(Qinghai University Affiliated Hospital), Miaozhou Wang(Qinghai University Affiliated Hospital), Yishuang Li(The Fourth People's Hospital of Ningxia Hui Autonomous Region), Guoshuang Shen(Qinghai University Affiliated Hospital)
Cited by 13
Related Papers
Induction of Pyroptosis and Its Implications in Cancer Management
|Frontiers in Oncology|2019|274
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial
|Nature Medicine|2024|121
Improving Outcomes of Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma: New Data and Ongoing Trials
|Frontiers in Oncology|2021|74
Schisandrin B Attenuates Cancer Invasion and Metastasis Via Inhibiting Epithelial-Mesenchymal Transition
|PLoS ONE|2012|63
Overexpression of miR529a confers enhanced resistance to oxidative stress in rice (Oryza sativa L.)
|Plant Cell Reports|2017|63